Skip to main content
TipRanks
Go Ultimate75% OFF

Aspen Aerogels (ASPN) AI Stock Analysis

1,240 Followers
ASPN

Aspen Aerogels

(NYSE:ASPN)

Select Model
Rating:61Neutral
Price Target:$5.00â–²(2.04% Upside)
Action:reiterated
Date:11/12/26

ASPN scores in the low 60s primarily because financial performance remains risky—profitability and margins have been volatile and recently weak despite improved cash flow. Offsetting that, technicals are constructive with the stock trading above major moving averages, and the latest earnings call was upbeat with guidance and operational improvements, though incident-related costs and ongoing GAAP losses limit the score. Valuation contributes negatively due to the negative P/E and lack of dividend support in the provided data.

Positive Factors
Multi-market revenue growthGrowth across both energy industrial and thermal barrier products reduces reliance on one application and supports broader customer diversification. Continued LNG infrastructure activity, EV programs, and European OEM expansion provide multiple avenues for revenue development over the next several quarters.
Negative Factors
Severe profitability deteriorationThe sharp decline from 2024 profitability to substantial 2025 and 2026 TTM losses shows that revenue scale has not yet translated into stable earnings. Gross-margin compression also limits operating leverage, making durable profitability dependent on improved mix, pricing, and cost control.

Aspen Aerogels Key Performance Indicators (KPIs)

Revenue by SegmentHighlights revenue contributions from different business areas, providing insight into which segments drive growth and profitability, and how the company balances its portfolio.

$0.00$25.00M$50.00M$75.00M$100.00M$125.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Thermal Barrier has become the company’s dominant, lumpy growth engine—driving rapid revenue expansion then a sharp pullback through 2025—which points to project timing and backlog volatility rather than steady end‑market traction. Energy Industrial is relatively stable but too small to offset that concentration. The disappearance of Subsea and Research Services underscores a narrowed product mix and higher concentration risk. The mid‑2026 uptick suggests some recovery or restocking, but cyclicality and order cadence remain the key risks to monitor.

Data provided by:The Fly

Aspen Aerogels (ASPN) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%ASPN+56.55%SPY+11.99%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$407.33M
Dividend Yield
―
Average Volume (3M)
1.02M
Price to Earnings (P/E)
-3.1
Beta (1Y)
1.91
Revenue Growth
-39.28%
EPS Growth
57.65%
Country
US
Employees
854
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Aspen Aerogels Business Overview & Revenue Model

Company Description

Aspen Aerogels, Inc. is a company dedicated to the development, manufacturing, and sale of advanced aerogel insulation products. These specialized solutions primarily serve the energy infrastructure and building materials sectors across a wide geogra...

How the Company Makes Money

Aspen Aerogels makes money primarily by manufacturing and selling aerogel-based insulation materials to customers, generating revenue from product shipments under commercial supply arrangements. Its key revenue streams include (1) Industrial insulati...

Aspen Aerogels Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q3-2026)|% Change Since:2.08%|Next Earnings Date:Feb 18, 2027
Earnings Call SentimentPositive

The call was strongly positive overall. Aspen exceeded Q3 revenue and adjusted EBITDA guidance, demonstrated substantially improved profitability and lower capital intensity, reported growth across energy industrial and thermal barriers, and announced initial traction in battery energy storage and data center infrastructure. The principal challenges were ongoing East Providence incident costs, pending insurance reimbursements, a remaining GAAP net loss, conservative GM production assumptions for Q4, and lumpy subsea revenue. However, the number and strength of the positive developments significantly outweighed the stated challenges.

Positive Updates

Q3 Revenue and Adjusted EBITDA Exceeded Guidance
Third-quarter revenue was $85.2 million, above the guided range of $65 million-$80 million and up 71% quarter-over-quarter and 17% year-over-year. Adjusted EBITDA was $19.8 million, above the guided range of $7 million-$15 million; management also described the result as approximately $20 million.

Negative Updates

East Providence Incident Costs Continued to Burden Results
Q3 included $14.7 million of incremental costs from the April East Providence incident that burdened gross margin, plus approximately $400,000 of incident-related operating expenses. Total incident-related charges added back to adjusted EBITDA were $15.1 million, including expedited freight, professional fees, and incremental external manufacturing costs.

Company Guidance

For the fourth quarter of 2026, Aspen expects total revenue to be between $60 million and $75 million, energy industrial revenue of approximately $35 million, GM production at an annualized rate of approximately 70,000-90,000 vehicles, and adjusted EBITDA between $5 million and $13 million, including incident-related costs of approximately $5 million-$10 million; management said it has the opportunity to be at the high end of those ranges. For full-year 2026, the implied outlook is $233 million-$248 million of revenue and $5.5 million-$13.5 million of adjusted EBITDA, with energy industrial targeted at approximately 20% growth. European thermal barrier revenue is expected to reach approximately $30 million in 2026 and approximately $50 million-$60 million in 2027, while subsea revenue is expected to be in the $10 million-$20 million range in 2027. CapEx and scheduled debt payments should total around $10 million in Q4 when excluding East Providence restoration CapEx, and the East Providence staged restart is expected to be completed in the first half of 2027.

Aspen Aerogels Financial Statement Overview

Summary

Financials are mixed: revenue scaled meaningfully and cash flow improved (positive operating cash flow in 2024–2026 TTM and positive free cash flow in 2026 TTM), but profitability and margins are highly unstable. The income statement shows a sharp deterioration after 2024 profitability, with large losses in 2025 and continued losses in 2026 TTM alongside significant gross margin compression, which materially raises risk despite a not-overly-levered balance sheet.

Income Statement

32Negative

Balance Sheet

55Neutral

Cash Flow

58Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue214.25M271.10M452.70M238.72M180.36M121.62M
Gross Profit5.18M46.00M182.90M56.92M4.98M9.94M
EBITDA-80.24M-331.29M49.57M-25.16M-68.41M-27.43M
Net Income-130.29M-389.55M13.38M-45.81M-82.74M-37.09M
Balance Sheet
Total Assets394.11M406.68M895.14M703.05M643.42M182.95M
Cash, Cash Equivalents and Short-Term Investments145.99M156.86M220.88M139.72M281.33M76.56M
Total Debt104.87M143.71M197.38M138.77M119.40M15.24M
Total Liabilities209.67M171.16M280.44M214.99M195.98M54.55M
Stockholders Equity184.44M235.52M614.71M488.06M447.44M128.41M
Cash Flow
Free Cash Flow19.95M-4.58M-40.71M-218.07M-272.37M-32.41M
Operating Cash Flow30.33M32.87M45.55M-42.61M-94.40M-18.63M
Investing Cash Flow-1.47M-37.45M-86.26M-175.46M-177.97M-13.78M
Financing Cash Flow-34.79M-58.13M122.02M75.48M478.37M92.47M

Aspen Aerogels Technical Analysis

Technical Analysis SentimentNegative
Last Price4.90

Price Trends

50DMA5.34Negative
100DMA5.30Negative
200DMA4.79Positive

Market Momentum

MACD-0.02Positive
RSI44.08Neutral
STOCH19.45Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASPN, the sentiment is Negative. The current price of 4.90 is below the 20-day moving average (MA) of 5.34, below the 50-day MA of 5.34, and above the 200-day MA of 4.79, indicating a neutral trend. The MACD of -0.02 indicates Positive momentum. The RSI at 44.08 is Neutral, neither overbought nor oversold. The STOCH value of 19.45 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ASPN.

Aspen Aerogels Risk Analysis

Aspen Aerogels disclosed 60 risk factors in its most recent earnings report. Aspen Aerogels reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Inadequate funding for the SEC and other government agencies, or a work slowdown or stoppage at those agencies as part of a broader federal government shutdown, could hinder their ability to hire and retain key leadership and other personnel, prevent new products and services from being developed or commercialized in a timely manner, or otherwise prevent those agencies from performing normal business functions on which the operation of our business may rely, which could negatively impact our business.Q4, 2025
2.Our relationships with automotive OEM customers involve multiple interconnected risks that could materially adversely impact our business, revenues, and profitability. These risks include but are not limited to being party to contracts without minimum commitments, pricing pressures, and cost reduction initiatives, selection of cell chemistries, battery pack system architectures, and customer market share and production declines.Q4, 2025
3.Changes in U.S. trade policy and the impact of tariffs may have a material adverse effect on our business, results of operations and financial condition. Changes in the U.S. regulatory framework may also impact EV demand, which could have a material adverse effect on our business, results of operations and financial condition.Q4, 2025

Aspen Aerogels Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

ASPN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AVNTAVNT70Outperform$4.07B22.517.52%2.48%5.24%58.61%
SOLSSOLS62Neutral$10.31B32.0021.49%0.34%――
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
ASPNASPN61Neutral$407.33M-3.10-63.10%―-39.28%57.65%
CBTCBT58Neutral$3.80B18.1413.35%2.49%0.83%-33.11%
MATVMATV51Neutral$619.81M6.7519.17%3.56%-0.43%―
MTXMTX46Neutral$1.86B-27.27-4.12%0.82%4.76%-19991.67%

* Basic Materials Sector Average

Performance Comparison

0%50%100%ASPNCBTMTXAVNTMATVSOLSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
ASPN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
ASPNAspen Aerogels Inc4.901.8058.06%
CBTCabot Corp74.0313.7922.88%
MTXMinerals Technologies59.451.061.82%
AVNTAvient Corporation44.3415.9456.14%
MATVMativ Holdings, Inc.11.23-0.56-4.76%
SOLSSolstice Advanced Materials, Inc.65.5921.2948.06%

Aspen Aerogels Corporate Events

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures

Aspen Aerogels Reports Strong Third-Quarter Revenue and EBITDA Growth

Positive
Nov 5, 2026

On November 2, 2026, Aspen’s board appointed Stacy D. Nieuwoudt as a Class III independent director, effective November 4, expanding the board from six to seven members. She joined the Audit Committee and Compensation & Leadership Development Committ...

Business Operations and StrategyFinancial Disclosures

Aspen Aerogels Highlights Growth Strategy in Investor Presentation

Positive
Sep 15, 2026

On September 15, 2026, Aspen Aerogels posted a new investor presentation outlining its operational scale, financial profile and strategic focus across energy industrial and electric vehicle thermal barrier markets. The deck highlights $202 million in...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026